Marker Therapeutics, Inc.

NASDAQ:MRKR

1.03 (USD) • At close April 11, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Omzet 6,591,0803.3119.0051.2420.4670.2130.2060.18300000000000000000.0250.121
Kosten van de omzet 010.4173.683.16318.88112.765123.9985.25100000000000000000.0030.039
Brutowinst 6,591,080-7.1065.324-1.921-18.414-12.552-123.792-5.06800000000000000000.0220.082
Brutowinstmarge 1-2.1460.591-1.547-39.448-58.874-600.948-27.68400000000000000000.8950.68
Onderzoek- en ontwikkelingskosten 13,467,84510.41726.13927.79518.88112.765123.9985.2513.81.7110.1890.6621.0570.2040.290.0930.1820.4260.1730.2481.0391.7270.83400.3410.295
Algemene en administratieve kosten 4,241,6077.47612.8212.92510.4729.97724.386.4124.6924.4483.1822.0034.422.4333.6514.0971.3112.080.7090.5941.6074.011.410.381.1280.834
Verkoop- en marketingkosten 00000000000000000000000000
Verkoop-, algemene en administratieve kosten 4,241,6077.47612.8212.92510.4729.97724.386.4124.6924.4483.1822.0034.422.4333.6514.0971.3112.080.7090.5941.6074.011.410.381.1280.834
Overige kosten 0-10.417-0.233-2.40700116.045-0.1830.0020000000.0040.0070.0060.0060.1480.0370.0420.04100.0210.018
Bedrijfskosten 17,709,4527.47638.95940.7229.35322.742148.37811.488.2616.1593.3712.6645.4782.6373.9424.1931.52.5110.8880.992.6835.7792.2850.381.491.147
Bedrijfsresultaat -11,118,372-14.581-29.946-39.478-28.886-22.529-148.172-11.663-8.492-6.159-3.371-3.31-6.223-2.637-3.942-5.382-2.279-2.511-0.888-0.99-2.683-5.779-2.285-0.38-1.467-1.065
Bedrijfsresultaat ratio -1.687-4.404-3.326-31.793-61.882-105.673-719.301-63.7110000000000000000-58.576-8.819
Totaal overige inkomsten en kosten netto 437,0100.5390.015-2.4010.181.1010.2140.4986.037-27.907-27.512-2.868-0.3740.608-1.149-0.269-0.696-1.38-0.4160.03000-0.0050.461-0.063
Inkomen voor belasting -10,681,362-14.042-29.931-41.879-28.706-21.428-147.958-10.982-2.455-34.066-30.883-5.533-5.858-2.029-5.091-4.462-2.196-3.891-1.304-0.99-2.683-5.779-2.285-0.385-1.292-1.127
Inkomen voor belasting ratio -1.621-4.241-3.324-33.727-61.497-100.509-718.263-59.9910000000000000000-51.568-9.339
Belastingkosten 49,9530.004-0.015-0.006-0.18-1.101-0.214-0.681-6.03727.89726.9370.466-1.11-1.287-0.0944.4622.1963.8911.3040.992.6835.7792.2850.3851.2921.127
Nettowinst -10.731-14.046-29.916-41.873-28.526-20.327-147.958-10.982-2.455-34.066-30.883-5.533-5.858-2.029-5.091-4.462-2.196-3.891-1.304-0.99-2.683-5.779-2.285-0.385-1.292-1.127
Nettowinstmarge -0-4.242-3.322-33.722-61.112-95.346-718.263-59.9910000000000000000-51.568-9.339
WPA (Winst Per Aandeel) -1.19-1.93-3.58-5.47-6.06-4.46-77.5-11.62-3.56-93.02-239.63-584.4-1,072.88-529.47-1,535.18-1,396.11-1,124.39-2,244.18-1,304,387-989,558-2,683,105-5,778,905-2,284,709-384,540-1,291,831-1,127,327
Verwaterde WPA -1.19-1.93-3.58-5.47-6.06-4.46-77.5-11.62-3.31-93.02-239.63-584.4-1,072.88-529.47-1,535.18-1,396.11-1,124.39-2,244.18-1,304,387-989,558-2,683,105-5,778,905-2,284,709-384,540-1,291,831-1,127,327
EBITDA -11,118,372-11.792-19.791-36.315-27.63-22.029-147.966-11.2976.037-34.055-30.308-3.776-5.5820-3.85-3.269-1.41-2.505-0.851-0.838-2.646-5.737-2.244-0.38-0.457-1.047
EBITDA ratio -1.687-3.561-2.198-29.246-59.193-103.329-718.301-61.7110000000000000000-18.251-8.672